Plasma IQ™
FDA Accepts Label Update for Plasma IQ, the First FDA-Cleared Handheld Plasma Energy Device
The removal of this specific contraindication was due in part to a compilation of literature provided to the FDA showing the safety and efficacy of the ablative device on skin tissue, particularly around the eye area. This label update allows Suneva to address treatment around the eye with patients in the United States.
